Fausther-Bovendo H - Search Results

1

Safety and Tolerability of the Adeno-Associated Virus Vector, AAV6.2FF, Expressing a Monoclonal Antibody in Murine and Ovine Animal Models.

Rghei AD, van Lieshout LP, McLeod BM, Pei Y, Lopes JA, Zielinska N, Baracuhy EM, Stevens BAY, Thomas SP, Yates JGE, Warner BM, Kobasa D, Fausther-Bovendo H, Kobinger GP, Karimi K, Thompson B, Bridle BW, Susta L, Wootton SK. Rghei AD, et al. Biomedicines. 2021 Sep 9;9(9):1186. doi: 10.3390/biomedicines9091186. Biomedicines. 2021. PMID: 34572372 Free PMC article.

2

Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents.

Wong G, Audet J, Fernando L, Fausther-Bovendo H, Alimonti JB, Kobinger GP, Qiu X. Wong G, et al. Vaccine. 2014 Sep 29;32(43):5722-9. doi: 10.1016/j.vaccine.2014.08.028. Epub 2014 Aug 27. Vaccine. 2014. PMID: 25173474 Free PMC article.

3

Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what's important?

Fausther-Bovendo H, Kobinger GP. Fausther-Bovendo H, et al. Hum Vaccin Immunother. 2014;10(10):2875-84. doi: 10.4161/hv.29594. Hum Vaccin Immunother. 2014. PMID: 25483662 Free PMC article. Review.

4

Optimization of Prime-Boost Vaccination Strategies Against Mouse-Adapted Ebolavirus in a Short-Term Protection Study.

Aviles J, Bello A, Wong G, Fausther-Bovendo H, Qiu X, Kobinger G. Aviles J, et al. J Infect Dis. 2015 Oct 1;212 Suppl 2:S389-97. doi: 10.1093/infdis/jiv175. Epub 2015 Jun 2. J Infect Dis. 2015. PMID: 26038398

5

Ebola virus infection induces autoimmunity against dsDNA and HSP60.

Fausther-Bovendo H, Qiu X, McCorrister S, Westmacott G, Sandstrom P, Castilletti C, Di Caro A, Ippolito G, Kobinger GP. Fausther-Bovendo H, et al. Sci Rep. 2017 Feb 9;7:42147. doi: 10.1038/srep42147. Sci Rep. 2017. PMID: 28181533 Free PMC article.

6

Contribution of Environment Sample-Based Detection to Ebola Outbreak Management.

Kapetshi J, Fausther-Bovendo H, Corbett C, Leung A, Ait-Ikhlef K, Nsio J, Aruna A, Kebela Ilunga B, Muyembe JJ, Formenty P, Kobinger GP. Kapetshi J, et al. J Infect Dis. 2018 Nov 22;218(suppl_5):S292-S296. doi: 10.1093/infdis/jiy366. J Infect Dis. 2018. PMID: 30325435

7

Increased mortality in survivors of Ebola virus disease.

Fausther-Bovendo H, Kobinger G. Fausther-Bovendo H, et al. Lancet Infect Dis. 2019 Nov;19(11):1152-1154. doi: 10.1016/S1473-3099(19)30429-3. Epub 2019 Sep 4. Lancet Infect Dis. 2019. PMID: 31494016 No abstract available.

8

Vaccine innovation spurred by the long wait for an Ebola virus vaccine.

Fausther-Bovendo H, Kobinger G. Fausther-Bovendo H, et al. Lancet Infect Dis. 2021 Apr;21(4):440-441. doi: 10.1016/S1473-3099(20)30515-6. Epub 2020 Nov 17. Lancet Infect Dis. 2021. PMID: 33217364 No abstract available.

9

Effects of Different Drug Combinations in Immunodeficient Mice Infected with an Influenza A/H3N2 Virus.

Mhamdi Z, Fausther-Bovendo H, Uyar O, Carbonneau J, Venable MC, Abed Y, Kobinger G, Boivin G, Baz M. Mhamdi Z, et al. Microorganisms. 2020 Dec 11;8(12):1968. doi: 10.3390/microorganisms8121968. Microorganisms. 2020. PMID: 33322333 Free PMC article.

10

Plant-made vaccines and therapeutics.

Fausther-Bovendo H, Kobinger G. Fausther-Bovendo H, et al. Science. 2021 Aug 13;373(6556):740-741. doi: 10.1126/science.abf5375. Science. 2021. PMID: 34385382 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page